Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

NCT05408910 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped new drug formulation by the manufacturer

Conditions

Cystic Fibrosis
Abdominal Pain
Small Bowel Disease

Interventions

DRUG: Rifaximin 550 MG Oral Tablet [XIFAXAN]
DRUG: Placebo

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]
[object Object]
[object Object]